353 related articles for article (PubMed ID: 28348151)
1. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
J Hosp Infect; 2015 Sep; 91(1):74-80. PubMed ID: 26169793
[TBL] [Abstract][Full Text] [Related]
3. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
[TBL] [Abstract][Full Text] [Related]
4. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
[TBL] [Abstract][Full Text] [Related]
5. Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
Kazakova SV; Baggs J; McDonald LC; Yi SH; Hatfield KM; Guh A; Reddy SC; Jernigan JA
Clin Infect Dis; 2020 Jan; 70(1):11-18. PubMed ID: 30820545
[TBL] [Abstract][Full Text] [Related]
6. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration.
Felsen CB; Dodds Ashley ES; Barney GR; Nelson DL; Nicholas JA; Yang H; Aydelotte ME; Karlic A; Nicholas NC; Petrone KK; Pine RD; Schabel SL; Medina-Walpole A; Dumyati GK
J Am Med Dir Assoc; 2020 Jan; 21(1):55-61.e2. PubMed ID: 31888865
[TBL] [Abstract][Full Text] [Related]
7. The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
Vaughn VM; Gandhi T; Conlon A; Chopra V; Malani AN; Flanders SA
Clin Infect Dis; 2019 Sep; 69(8):1269-1277. PubMed ID: 30759198
[TBL] [Abstract][Full Text] [Related]
8. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
[TBL] [Abstract][Full Text] [Related]
9. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection.
Brumley PE; Malani AN; Kabara JJ; Pisani J; Collins CD
J Antimicrob Chemother; 2016 Mar; 71(3):836-40. PubMed ID: 26661392
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
DiDiodato G; McArthur L
PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.
Walbrown MA; Aspinall SL; Bayliss NK; Stone RA; Cunningham F; Squier CL; Good CB
J Manag Care Pharm; 2008; 14(1):34-40. PubMed ID: 18240880
[TBL] [Abstract][Full Text] [Related]
12. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.
Kallen AJ; Thompson A; Ristaino P; Chapman L; Nicholson A; Sim BT; Lessa F; Sharapov U; Fadden E; Boehler R; Gould C; Limbago B; Blythe D; McDonald LC
Infect Control Hosp Epidemiol; 2009 Mar; 30(3):264-72. PubMed ID: 19215193
[TBL] [Abstract][Full Text] [Related]
13. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
[TBL] [Abstract][Full Text] [Related]
14. Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use.
Wenisch JM; Equiluz-Bruck S; Fudel M; Reiter I; Schmid A; Singer E; Chott A
Antimicrob Agents Chemother; 2014 Sep; 58(9):5079-83. PubMed ID: 24936597
[TBL] [Abstract][Full Text] [Related]
15. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
Chia BY; Teo JQ; Lee W; Liew YX; Ee RP; Chlebicki MP; Oon LL; Kwa AL
J Glob Antimicrob Resist; 2019 Jun; 17():312-315. PubMed ID: 30682564
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.
Wieczorkiewicz JT; Lopansri BK; Cheknis A; Osmolski JR; Hecht DW; Gerding DN; Johnson S
Antimicrob Agents Chemother; 2016 Jan; 60(1):418-23. PubMed ID: 26525793
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial stewardship program achieved marked decrease in Clostridium difficile infections in a Veterans Hospital.
Morgan F; Belal M; Lisa B; Ford F; LeMaitre B; Psevdos G
Am J Infect Control; 2020 Sep; 48(9):1119-1121. PubMed ID: 32035688
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011.
Kanerva M; Ollgren J; Voipio T; Mentula S; Lyytikäinen O
Infect Dis (Lond); 2015 Aug; 47(8):530-5. PubMed ID: 25832317
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial stewardship and Clostridium difficile-associated diarrhea.
Piacenti FJ; Leuthner KD
J Pharm Pract; 2013 Oct; 26(5):506-13. PubMed ID: 23946208
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
